Q4 2022 13F Holders as of 12/31/2022
-
Type / Class
-
Equity / Common Shares
-
Shares outstanding
-
29.9M
-
Number of holders
-
33
-
Total 13F shares, excl. options
-
8.47M
-
Shares change
-
-307K
-
Total reported value, excl. options
-
$91.7M
-
Value change
-
+$3.08M
-
Put/Call ratio
-
0.38
-
Number of buys
-
18
-
Number of sells
-
-10
-
Price
-
$10.89
Significant Holders of Profound Medical Corp. - Common Shares (PROF) as of Q4 2022
43 filings reported holding PROF - Profound Medical Corp. - Common Shares as of Q4 2022.
Profound Medical Corp. - Common Shares (PROF) has 33 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 8.47M shares
of 29.9M outstanding shares and own 28.35% of the company stock.
Largest 10 shareholders include GAGNON SECURITIES LLC (1.78M shares), FIL Ltd (1.23M shares), LETKO, BROSSEAU & ASSOCIATES INC (1.18M shares), NATIONAL BANK OF CANADA /FI/ (899K shares), Timelo Investment Management Inc. (667K shares), Gagnon Advisors, LLC (648K shares), ROYCE & ASSOCIATES LP (548K shares), Royal Bank of Canada (400K shares), Raymond James Financial Services Advisors, Inc. (318K shares), and Zweig-DiMenna Associates LLC (297K shares).
This table shows the top 33 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.